Skip to content

Search

GAMA project

This study investigated host gene expression in response to new HIV infection.

The immortal legacy of Jette Ford

The Institute farewelled one of its most treasured employees this year, as The Kids Cancer Centre research officer Jette Ford closed the door on a quietly stellar 37-year career which has helped to change the face of cancer research in WA and around the world.

CliniKids puts the ‘evidence’ in evidence-based practice

Autism researchers at The Kids have led the most comprehensive review of the evidence for autism intervention ever compiled

Putting malaria on the map

A global network of researchers led by Kerry M Stokes Chair of Child Health, Professor Pete Gething, is working to help support informed decision-making for malaria control at international, regional and national scales.

The one-stop app helping to keep kids safe online

Parents, carers and educators have embraced an innovative tool in the battle to keep kids safe online - Beacon, an Australia-first, evidence-based cyber safety app.

Precision health accelerator takes some of the guesswork out of research

Running any research project is a feat of logistical gymnastics – and often, you don’t know what can go wrong until it happens.

Teaching educators to see neurodisability through kids’ eyes

Findings from the Banksia Hill Project revealed 89% of young people in detention who were assessed as part of the project had at least one form of severe neurodevelopmental impairment.

Cutting-edge CliniKids keeps families up-to-date

CliniKids, the first stand-alone clinical service offered by The Kids Research Institute Australia, was launched in October 2019 and is already delivering benefits for families with children who are developing differently.

Perseverance pays off for critically ill patients

A legal change fought for by The Kids, consumer advocates, and others within the health sector – and hastened by the COVID-19 crisis – has brought WA into line with the rest of Australia, allowing critically ill or incapacitated patients access to potentially life-saving clinical trials.